SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-215463
Filing Date
2018-07-10
Accepted
2018-07-10 16:31:35
Documents
3
Period of Report
2018-07-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d391430d8k.htm 8-K 19885
2 EX-99.1 d391430dex991.htm EX-99.1 10365
3 GRAPHIC g391430image000180.jpg GRAPHIC 12994
  Complete submission text file 0001193125-18-215463.txt   49508
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 18947278
SIC: 8731 Services-Commercial Physical & Biological Research